Skip to main content
Professional Technical IVT

β-ketothiolase deficiency

Pronunciation: BAY-tah KEE-toe-THIGH-oh-lace

Mitochondrial acetoacetyl-CoA thiolase deficiency, detected through elevated 2-methylacetoacetyl-CoA and tiglylcarnitine levels.

Full Definition

β-ketothiolase deficiency is an organic acidemia affecting isoleucine catabolism, caused by deficiency of mitochondrial acetoacetyl-CoA thiolase. Patients may present with ketoacidotic episodes during illness or fasting. Newborn screening detects the condition through elevated C5:1 (tiglylcarnitine) levels, though some cases may be missed if collected during asymptomatic periods. Treatment involves protein restriction and avoidance of prolonged fasting.

Usage

Usage note: Use Greek letter β or spell out 'beta'; avoid numeric '2' in formal documentation.

In Context

  • "Elevated tiglylcarnitine on screening prompted testing for β-ketothiolase deficiency." — laboratory report
  • "β-ketothiolase deficiency may present with episodic ketoacidosis during illness." — clinical description

Also known as

mitochondrial acetoacetyl-CoA thiolase deficiency MAT deficiency T2 deficiency

Don't confuse with

3-methylglutaconic aciduria HMG-CoA lyase deficiency

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON